In summary, bronchiectasis complications include frequent exacerbations, cardiovascular events, hemoptysis, nontuberculous mycobacterial lung infections, respiratory failure, and even death.

Being overweight or obese may lower all-cause mortality risks in non–cystic fibrosis (CF) bronchiectasis patients, while ...

Participants with suspected bronchiectasis had a 15% higher risk for 10-year mortality compared with those without airway thickening (difference in mortality probability, 0.15; 95% CI, 0.09 to 0.21).

Among Chinese adults with bronchiectasis and exacerbations in the past year, 24-week dipeptidylpeptidase-1 inhibitor HSK31858 lowered exacerbation incidence, according to a poster at the European ...

Having a chronic respiratory infection in addition to bronchiectasis heightened the risk for an exacerbation and hospitalization within 2 years of diagnosis, according to results published in BMC ...

USA: Individuals with rheumatoid arthritis (RA) who also suffer from associated lung conditions face a significantly higher ...

Bronchiectasis, a condition defined by widened lung airways, cough and sputum production, and frequent infections, often presents along with chronic obstructive pulmonary disease (COPD). This ...

Most bronchiectasis patients experience loss of lung function over time due to the irreversible damage caused by the progressive disease. But in this large, international, randomized ASPEN trial ...

Change from baseline in the Quality of Life Bronchiectasis (QOL-B) Respiratory score: 2 points (P =.0594) and 3.8 points (P =.0004; nominal significant p-value).

New drug shows promise for treating bronchiectasis Date: May 2, 2025 Source: University of Connecticut Summary: Results of a large, global clinical trial spanning five continents with over 1,700 ...